Details:

Alternative Title:
Vaccine
Personal Author:
Byrd, Kathy K. ; Lu, Peng-jun ; Murphy, Trudy V. ;
Byrd, Kathy K. ; Lu, Peng-jun ; Murphy, Trudy V. ; Less -
Description:
Background: Recent data suggest that adults with diabetes are at increased risk of incident hepatitis B infection and may suffer increased morbidity or mortality from chronic hepatitis B infection. In October 2011, the Advisory Committee on Immunization Practices (ACIP) recommended hepatitis B vaccination (HepB) for persons with diabetes aged 19–59 years and stated that persons with diabetes aged 60 years and older should be considered for vaccination. Objective: To determine HepB coverage among persons with diabetes aged ≥19 years prior to implementation of the new ACIP recommendation and to determine predictors for vaccination. Methods: We used the 2009 National Health Interview Survey to determine weighted proportions of self-reported HepB coverage (≥1 and ≥3 doses) among persons with diabetes aged ≥19 years. A multivariable logistic regression analysis was performed to determine factors independently associated with vaccination. Results: Overall, 19.5% (95% CI: 17.4–21.6%) and 16.6% (14.7–18.6%) of persons with diabetes, aged ≥19 years, reported receiving ≥1 and ≥3 doses of HepB, respectively, compared with 30.3% (29.4–31.3%) and 26.5% (25.5–27.4%) among persons without diabetes. While unadjusted HepB coverage was higher among persons without diabetes, diabetes status was not associated with ≥1 or ≥3 dose vaccination. Among persons with diabetes, being a healthcare provider (OR 4.2, 2.5–7.0), ever tested for HIV (OR 2.6, 1.8–3.6), high-risk behaviors (OR 1.8, 1.0–3.4, P-value = 0.053) and having some college education (OR 1.7, 1.2–2.4) were all independently associated with vaccination. Conclusion: HepB coverage among persons with diabetes is low. These data can be used to provide a baseline for measuring future progress toward vaccination of persons with diabetes.
Subject:
[+]
Adult
Aged
Cross-Sectional Studies
Diabetes Complications
Female
Hepatitis B
Hepatitis B Vaccines
Humans
Male
Middle Aged

Source:
Vaccine. 30(23):3376-3382. ;
Pubmed ID:
22472793
Pubmed Central ID:
PMC6215488
Document Type:
Journal Article ;
Funding:
CC999999/Intramural CDC HHS/United States ;
Place as Subject:
United States ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:95f81357121f462ce670f975673efd2862dd1d2058146aa4436f129918f34110
File Type:

Supporting Files

• nihms-994231.nxml

  xml

More +